価格表

在庫・価格 : 2024年03月29日 22時00分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
TIM-3/Fc Chimera, Human, Recombinant, Carrier-free
データシート
2365-TM-050 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥91,000
(未発注)
追加

在庫・価格 : 2024年03月29日 22時00分 現在

TIM-3/Fc Chimera, Human, Recombinant, Carrier-free

  • 商品コード:2365-TM-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥91,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zhao J et al. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J. Immunol. 2009 May;182(10):6618-24
Zhao J et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
2 Ju Y et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 2010 Mar;52(3):322-9
Ju Y et al
2010/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Vega-Carrascal I et al. Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J. Immunol. 2011 Mar;186(5):2897-909
Vega-Carrascal I et al
2011/01/01
Application: Bioassay,Enzyme Assay, Sample Type: BALF,Whole Cells PubMed
4 Ivie SE et al. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ?-toxin. PLoS ONE 2011;6(3):e17787
Ivie SE et al
2011/01/01
Application: Binding Assay, Sample Type: Buffer - see notes PubMed
5 Wu W et al. Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B. Eur. J. Immunol. 2012 May;42(5):1180-91
Wu W et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Nebbia G et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE 2012;7(10):e47648
Nebbia G et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Leitner J et al. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 2013 Mar;9(3):e1003253
Leitner J et al
2013/01/01
Application: Bioassay, Sample Type: cell lines PubMed
8 Kojima R et al. Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line. PLoS ONE 2014;9(1):e86106
Kojima R et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
9 Ayala-Lujan JL et al. Broad spectrum activity of a lectin-like bacterial serine protease family on human leukocytes. PLoS ONE 2014;9(9):e107920
Ayala-Lujan JL et al
2014/01/01
Application: Cleavage,Substrate for Enzyme Digestion, Sample Type: Whole Cells,protein PubMed
10 Wang S et al. Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface. Sci Rep 2015;5:9013
Wang S et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Zhao J et al. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J. Immunol. 2009 May;182(10):6618-24
    Zhao J et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ju Y et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 2010 Mar;52(3):322-9
    Ju Y et al
    2010/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Vega-Carrascal I et al. Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J. Immunol. 2011 Mar;186(5):2897-909
    Vega-Carrascal I et al
    2011/01/01
  • 備考:
    Application: Bioassay,Enzyme Assay, Sample Type: BALF,Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ivie SE et al. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ?-toxin. PLoS ONE 2011;6(3):e17787
    Ivie SE et al
    2011/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Buffer - see notes
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Wu W et al. Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B. Eur. J. Immunol. 2012 May;42(5):1180-91
    Wu W et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Nebbia G et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE 2012;7(10):e47648
    Nebbia G et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Leitner J et al. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 2013 Mar;9(3):e1003253
    Leitner J et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: cell lines
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Kojima R et al. Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line. PLoS ONE 2014;9(1):e86106
    Kojima R et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Ayala-Lujan JL et al. Broad spectrum activity of a lectin-like bacterial serine protease family on human leukocytes. PLoS ONE 2014;9(9):e107920
    Ayala-Lujan JL et al
    2014/01/01
  • 備考:
    Application: Cleavage,Substrate for Enzyme Digestion, Sample Type: Whole Cells,protein
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Wang S et al. Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface. Sci Rep 2015;5:9013
    Wang S et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed